title: Physiologically assessed collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.
authors.forename: P
authors.initials: P
authors.lastname: Lambiase
authors.forename: R
authors.initials: R
authors.lastname: Edwards
authors.forename: C A
authors.initials: CA
authors.lastname: Bucknall
authors.forename: M S
authors.initials: MS
authors.lastname: Marber
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D003097:Collateral Circulation; D003327:Coronary Disease / Q000097:blood / Q000503:physiopathology*; D003331:Coronary Vessels / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D016228:Endothelial Growth Factors / Q000097:blood; D016222:Fibroblast Growth Factor 2 / Q000097:blood; D006133:Growth Substances / Q000097:blood*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans
chemical_list: D000925:Anticoagulants; D016228:Endothelial Growth Factors; D006133:Growth Substances; D016222:Fibroblast Growth Factor 2; D006493:Heparin